| Dr Paul Vartabedian, DDS | |
|
1090 N Forbes St, Lakeport, CA 95453-4341 | |
| (707) 263-1496 | |
| (707) 263-1498 |
| Full Name | Dr Paul Vartabedian |
|---|---|
| Gender | Male |
| Speciality | Dentist - Prosthodontics |
| Location | 1090 N Forbes St, Lakeport, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518038611 | NPI | - | NPPES |
| 39583 | Other | CA | DENTAL LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223P0700X | Dentist - Prosthodontics | 39583 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Paul Vartabedian, DDS 1090 N Forbes St, Lakeport, CA 95453-4341 Ph: (707) 263-1496 | Dr Paul Vartabedian, DDS 1090 N Forbes St, Lakeport, CA 95453-4341 Ph: (707) 263-1496 |
News Archive
TWi Biotechnology Inc. today announced interim results from the ongoing Phase 2 proof of concept clinical study evaluating AC-201 CR as an oral uricosuric and anti-inflammatory agent for the treatment of hyperuricemia and prevention of gout flares combining with febuxostat, a xanthine oxidase inhibitor.
Vanda Pharmaceuticals Inc. today announced its plans to initiate a Phase IIb/III clinical trial of tasimelteon in patients with Major Depressive Disorder (MDD). The trial is expected to begin during the second half of 2011. Tasimelteon is currently being evaluated in Phase III clinical trials for the treatment of Non-24-Hour Sleep/Wake Disorder (N24HSWD) in blind individuals without light perception.
As of Oct. 1, the health law's online marketplaces have been up and running for a year. News outlets offer status reports on what appears to have gone well, what problems remain as the second open enrollment period approaches and how these factors are playing politically.
The number of CT angiograms (CTAs) has gone up substantially, but the number of pulmonary emboli found has not, leading some researchers to question the utilization of this procedure.
Zyga Technology announced today that it had raised $25 million in a Series C financing led by new investor Versant Ventures of Menlo Park, California. Joining Versant in this round are existing investors Split Rock Partners, Domain Associates, and MB Venture Partners. With this investment, Kirk Nielsen, Managing Director, Versant Ventures will join the board of directors of Zyga.
› Verified 5 days ago
Dr. Alexander Russell Mcgeoch, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 1870 N High St, Lakeport, CA 95453 Phone: 707-263-5427 Fax: 707-263-3925 | |
Tina Ngo, DDS Dentist Medicare: Medicare Enrolled Practice Location: 5335 Lakeshore Blvd, Lakeport, CA 95453 Phone: 707-263-7725 | |
John Granville Jenkins, DDS Dentist Medicare: Medicare Enrolled Practice Location: 5335 Lakeshore Blvd, Lakeport, CA 95453 Phone: 707-263-0196 Fax: 707-263-1439 | |
Dr. Marlin Noelia Duran, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 925 Bevins Ct, Lakeport, CA 95453 Phone: 707-263-8382 | |
Dr. James Edward Milani, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 800 11th St, Lakeport, CA 95453 Phone: 707-263-9992 Fax: 707-263-9994 | |
Dr. Jonathan Michael Drew, DDS, MS Dentist Medicare: Not Enrolled in Medicare Practice Location: 120 9th St, Lakeport, CA 95453 Phone: 707-263-5390 | |
Lawerence G Cannon, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 925 Bevins Court, Lakeport, CA 95453 Phone: 707-263-8382 Fax: 707-263-0329 |